FATE
Fate Therapeutics Inc.
$1.03
+$0.03(+3.00%)
39
Overall
60
Value
18
Tech
--
Quality
Market Cap
$137.24M
Volume
1.07M
52W Range
$0.66 - $3.43
Target Price
$4.65
Key Metrics Overview
| Market Cap | $137.24M | P/E Ratio | N/A |
| 52W High | $3.43 | 52W Low | $0.66 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 9.9% | 52W Position | 13.4% |
| Overall Score | 39 | Value Score | 60 |
| Quality Score | -- | Technical Score | 18 |
Growth Analysis
| EPS Current Est | $-1.14 | EPS Next Est | $-1.18 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.03 | +3.0% | 1.07M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |